Lucid Group Inc. (LCID): Price and Financial Metrics


Lucid Group Inc. (LCID): $24.11

-0.35 (-1.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LCID Stock Price Chart Interactive Chart >

Price chart for LCID

LCID Price/Volume Stats

Current price $24.11 52-week high $64.86
Prev. close $24.46 52-week low $9.60
Day low $23.41 Volume 16,383,900
Day high $24.19 Avg. volume 29,419,479
50-day MA $22.70 Dividend yield N/A
200-day MA $24.20 Market Cap 39.02B

Lucid Group Inc. (LCID) Company Bio


Lucid Motors, Inc. is an American electric vehicle manufacturer headquartered in Newark, California. Lucid's other divisions include energy storage, and original equipment manufacturing. The company was founded in 2007.


LCID Latest News Stream


Event/Time News Detail
Loading, please wait...

LCID Latest Social Stream


Loading social stream, please wait...

View Full LCID Social Stream

Latest LCID News From Around the Web

Below are the latest news stories about Lucid Group Inc that investors may wish to consider to help them evaluate LCID as an investment opportunity.

3 EV Stocks That Could Win the Electric Vehicle Revolution

The electric vehicle market remains strong with and is forecast to reach $917 billion globally in 2028.

Joel Baglole on InvestorPlace | October 21, 2021

Dear Elon Musk, Tesla Investors Want Answers to These Q3 Earnings Questions

Dear Elon, TSLA stock investors have plenty of questions heading into your Q3 earnings call.

Joanna Makris on InvestorPlace | October 20, 2021

Cash-burning Canoo Can’t Seem To Join Peers on EV Production Bandwagon

GOEV stock isn't going to amount to much at this rate.

Alex Sirois on InvestorPlace | October 20, 2021

We Nailed the Low in Lucid Motors Stock—What the Chart Says Now

Lucid Motors has seen a strong move from the lows, but the valuation remains daunting.

Bret Kenwell on InvestorPlace | October 20, 2021

AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging Today

Atea Pharmaceuticals (AVIR) stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update.

William White on InvestorPlace | October 19, 2021

Read More 'LCID' Stories Here

LCID Price Returns

1-mo -3.37%
3-mo -0.58%
6-mo 17.32%
1-year 149.84%
3-year N/A
5-year N/A
YTD 140.86%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.947 seconds.